Synthesis, Characterization, and Biological Activity of a Novel Series of Benzo[4,5]imidazo[2,1-<i>b</i>]thiazole Derivatives as Potential Epidermal Growth Factor Receptor Inhibitors
Based on the analysis of epidermal growth factor receptor (EGFR) complexes with gefitinib with molecular docking, the scaffold-hopping strategy, combination of the active substructures, and structural optimization of EGFR inhibitors, a novel series of benzo[4,5]imidazo[2,1-<i>b</i>]thiaz...
Main Authors: | Xinshan Deng, Xiaoyu Tan, Tiantian An, Qingqing Ma, Zhe Jin, Ce Wang, Qingguo Meng, Chun Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/4/682 |
Similar Items
-
Synthesis, anticancer and apoptosis-inducing activities of quinazoline–isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies
by: Adel S. El-Azab, et al.
Published: (2017-01-01) -
Benzo[4,5]imidazo[2,1-b]thiazole-2-carbaldehyde
by: Basappa Yallur, et al.
Published: (2016-05-01) -
Discovery of 4,5-Dihydro-1H-thieno[2′,3′:2,3]thiepino [4,5-c]pyrazole-3-carboxamide Derivatives as the Potential Epidermal Growth Factor Receptors for Tyrosine Kinase Inhibitors
by: Jia Ke, et al.
Published: (2018-08-01) -
Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment
by: Yi Le, et al.
Published: (2020-01-01) -
3,4-Dihydro-2H-benzo[4,5]imidazo[2,1-b][1,3]thiazin-3-ol
by: Latifa El Ouasif, et al.
Published: (2017-03-01)